Citadel Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,031,759
| Closed | -$82.4M | – | 14939 |
|
|
2021
Q1 | $82.4M | Buy |
1,031,759
+958,309
| +1,305% | +$74.8M | 0.02% | 695 |
|
|
2020
Q4 | $5.79M | Sell |
73,450
-10,936
| -13% | -$641K | ﹤0.01% | 3432 |
|
|
2020
Q3 | $3.71M | Sell |
84,386
-53,596
| -39% | -$2.64M | ﹤0.01% | 3608 |
|
|
2020
Q2 | $6.1M | Sell |
137,982
-218,563
| -61% | -$8.15M | ﹤0.01% | 2812 |
|
|
2020
Q1 | $12.8M | Buy |
356,545
+305,433
| +598% | +$17.4M | 0.01% | 1628 |
|
|
2019
Q4 | $3.62M | Sell |
51,112
-4,211
| -8% | -$305K | ﹤0.01% | 3528 |
|
|
2019
Q3 | $4.14M | Buy |
55,323
+49,094
| +788% | +$4.16M | ﹤0.01% | 3369 |
|
|
2019
Q2 | $502K | Sell |
6,229
-59,572
| -91% | -$4.19M | ﹤0.01% | 6815 |
|
|
2019
Q1 | $4.4M | Buy |
65,801
+47,182
| +253% | +$3.57M | ﹤0.01% | 3187 |
|
|
2018
Q4 | $1.39M | Buy |
+18,619
| New | +$1.54M | ﹤0.01% | 4765 |
|
|
2018
Q3 | – | Sell |
-92,748
| Closed | -$8.83M | – | 9924 |
|
|
2018
Q2 | $9.12M | Buy |
+92,748
| New | +$10.4M | ﹤0.01% | 2038 |
|
|
2018
Q1 | – | Sell |
-3,161
| Closed | -$354K | – | 9002 |
|
|
2017
Q4 | $325K | Sell |
3,161
-26,512
| -89% | -$2.64M | ﹤0.01% | 6331 |
|
|
2017
Q3 | $2.79M | Buy |
29,673
+10,797
| +57% | +$852K | ﹤0.01% | 3009 |
|
|
2017
Q2 | $1.47M | Buy |
18,876
+9,470
| +101% | +$711K | ﹤0.01% | 3562 |
|
|
2017
Q1 | $753K | Sell |
9,406
-8,631
| -48% | -$686K | ﹤0.01% | 4429 |
|
|
2016
Q4 | $1.42M | Sell |
18,037
-41,579
| -70% | -$3.23M | ﹤0.01% | 3367 |
|
|
2016
Q3 | $4.65M | Sell |
59,616
-130,902
| -69% | -$9.5M | ﹤0.01% | 2058 |
|
|
2016
Q2 | $13.1M | Buy |
190,518
+122,745
| +181% | +$8.47M | 0.01% | 1053 |
|
|
2016
Q1 | $4.84M | Buy |
67,773
+50,960
| +303% | +$3.2M | 0.01% | 1817 |
|
|
2015
Q4 | $1.04M | Buy |
+16,813
| New | +$1.03M | ﹤0.01% | 3507 |
|
|
2015
Q2 | – | Sell |
-12,672
| Closed | -$602K | – | 9243 |
|
|
2015
Q1 | $602K | Sell |
12,672
-7,878
| -38% | -$349K | ﹤0.01% | 4641 |
|
|
2014
Q4 | $889K | Buy |
+20,550
| New | +$840K | ﹤0.01% | 3907 |
|
|
2014
Q3 | – | Sell |
-924
| Closed | -$34K | – | 8531 |
|
|
2014
Q2 | $34K | Buy |
+924
| New | +$31.3K | ﹤0.01% | 7013 |
|
|
2014
Q1 | – | Sell |
-3,432
| Closed | -$113K | – | 8097 |
|
|
2013
Q4 | $116K | Buy |
3,432
+599
| +21% | +$20.8K | ﹤0.01% | 5492 |
|
|
2013
Q3 | $90K | Buy |
+2,833
| New | +$75.3K | ﹤0.01% | 5416 |
|
Citadel Advisors's CMD Position: Q2 2021 in Review
Citadel Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,031,759 shares — an estimated $82.4M sold.
Citadel Advisors first reported a position in CMD in Q3 2013 and held it in 25 quarters. The position peaked at $82.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Citadel Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Citadel Advisors sold 1,031,759 Cantel Medical Corporation shares in Q2 2021, an estimated $82.4M.
- Citadel Advisors first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 25 quarters.
- Citadel Advisors's Cantel Medical Corporation position peaked at $82.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.